HIGHFDA DEVICE

Brahms PlGF Plus KRYPTOR 859075N Recall Expands to 5,254 Units Worldwide (2026)

Brahms GmbH recalled 5,254 units of the PlGF Plus KRYPTOR in vitro diagnostic test worldwide after reports of QC values out of range at QC Level 1. The issue may cause falsely elevated sFlt-1/PlGF ratios and higher risk classifications for preeclampsia progression. Stop using the device immediately and follow manufacturer recall instructions.

Official notice
Brahms GmbHHealth & Personal CareMedical DevicesUDI: 04260157632196. Lot(Expiration): 59172(2026-11-23)859075N(2026-11-23)

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
March 12, 2026
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
March 12, 2026
Hazard Level
HIGH
Brand
Brahms GmbH
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
Nationwide (50 states)
At-Risk Groups
GENERAL, PREGNANT, PREGNANT

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Brahms GmbH
Product type
In Vitro Diagnostic Test
Model numbers
UDI: 04260157632196. Lot(Expiration): 59172(2026-11-23), 859075N(2026-11-23)
Sold at
Unknown
Where affected
Nationwide

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    March 12, 2026

  2. Reported by FDA DEVICE

    April 15, 2026

  3. RecallRadar source check

    April 22, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Customers have observed quality control values out of range at the lowest quality control level (QC Level 1) for the PIGF assay which require troubleshooting steps to resolve. If Quality Controls are not performed according to the Instructions for Use, the underestimation of QC1 may go undetected and could contribute to falsely elevated sFlt-1/PlGF ratio results. A falsely elevated sFlt-1/PlGF ratio may result in a higher-risk classification for progression to preeclampsia with severe features potentially leading to intensified clinical monitoring.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Brahms GmbH or your healthcare provider for instructions

About This Product

PlGF Plus KRYPTOR is an in vitro diagnostic test measuring placental growth factor for preeclampsia risk assessment. Used in clinical settings to guide patient monitoring.

Why This Is Dangerous

Out-of-range QC values at the lowest QC level may lead to underestimation during QC checks, resulting in falsely high sFlt-1/PlGF ratios and misclassification of preeclampsia risk.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Potential for incorrect patient risk stratification and inappropriate clinical decisions; immediate action required.

Practical Guidance

How to identify if yours is affected

  1. Check catalog number 859075N and UDI 04260157632196
  2. Check lot 59172 with expiration 2026-11-23 for affected units
  3. Verify distribution aligns with the list of US states and countries provided in recall

Where to find product info

Look up the FDA recall page Z-1795-2026 for details; contact Brahms GmbH for instructions

What timeline to expect

Refunds or replacements coordinated by Brahms GmbH; follow official guidance

If the manufacturer is unresponsive

  • Escalate to regulatory authorities if the manufacturer is slow to respond
  • Document all attempts to reach the company and keep records

How to prevent similar issues

  • Always run QC as per Instructions for Use
  • Validate QC procedures before reporting results
  • Consult Brahms GmbH guidance for any anomalies
  • Track lot and catalog numbers carefully for future recalls

Documentation advice

Keep recall notice, QC logs, testing results, supplier communications

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Brand: Brahms GmbH. Product: PlGF Plus KRYPTOR. Catalog Number: 859075N. UDI: 04260157632196. Lot/Expiration: 59172(2026-11-23); 859075N(2026-11-23). Distribution: Worldwide. Recall Date: 2026-03-12. Status: ACTIVE.

Reported Incidents

No explicit injury or patient harm incidents are described in the provided data.

Key Facts

  • 5,254 total units recalled
  • QC Level 1 out-of-range values
  • Worldwide distribution including US states NC, TX, MN, UT, NY, FL, OH, IL, CT, CA, GA
  • Lot: 59172 with expiration 2026-11-23
  • Catalog Number: 859075N

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERALPREGNANTPREGNANT
Injury Types
OTHER

Product Details

Model Numbers
UDI: 04260157632196. Lot(Expiration): 59172(2026-11-23)
859075N(2026-11-23)
Affected States
Nationwide
Report Date
April 15, 2026
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more